- Conditions
- Head and Neck Cancer, Liver Cancer, Prostate Cancer, Recurrent Adenocarcinoma
- Interventions
- MRI Simulator, Radiation Therapy
- Device · Radiation
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2030
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
Condition Directory
Head and Neck Cancer clinical trials
Directory of U.S. ClinicalTrials.gov public records for Head and Neck Cancer. Browse Head and Neck Cancer recruiting trials, filter by phase, sponsor, location, or intervention, and open the official ClinicalTrials.gov study record for each result.
By the Clinical Trials Finder editorial team Guidance last reviewed June 10, 2026 Data synced August 30, 2026 Report an issue
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
170
Shown on this page
12
Local recruiting
92
Local phase groups
6
How Head and Neck Cancer studies are organized in the registry
Most records use the formal phrase “squamous cell carcinoma of the head and neck” or the abbreviation HNSCC, and site-specific terms like “oropharyngeal” mark distinct subsets. HPV status is a common population-defining label in this portfolio, and combined-modality studies (radiation plus systemic therapy) are frequent.
- 54% of the 170 locally indexed Head and Neck Cancer records are currently marked recruiting.
- The most common phase group in the local index is Phase 2 (66 records).
- The most frequent sponsor is M.D. Anderson Cancer Center (12 records).
- The most listed study location is Houston, Texas (37 records).
Terms that often appear in related listings
These describe how studies tend to be titled and grouped on ClinicalTrials.gov — they are search vocabulary, not medical guidance.
Showing 1–12 of 170 matching trials for Head and Neck Cancer.
Indexed local directory records.
Phase distribution
Phase 2 66
Not applicable 45
Phase 1 36
Early Phase 1 5
Phase 3 5
Phase 4 1
Top locations
Top sponsors
Top therapies
Indexed official records
Open in full search- Conditions
- Head and Neck Cancer
- Interventions
- Cemiplimab, cemiplimab+fianlimab
- Drug
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Brain Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Genitourinary Cancer, Gynecologic Cancer, Head and Neck Cancer, Hodgkin Lymphoma, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Lymphoid Leukemia, Melanoma, Mycosis Fungoides, Myeloma Multiple, Non-hodgkin Lymphoma, Ovarian Cancer, Pancreas Cancer, Prostate Cancer, Sarcoma, Urinary Bladder Cancer
- Interventions
- Placebo, Riluzole
- Drug
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma HNSCC
- Interventions
- Accelerated radiotherapy, Conventional radiotherapy
- Radiation
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 3
- States / cities
- Charlotte, North Carolina • Winston-Salem, North Carolina • Milwaukee, Wisconsin
- Conditions
- Head and Neck Cancer, Non Small Cell Lung Carcinoma NSCLC, Prostate Cancer
- Interventions
- Biograph Vision Quadra scanner, PET/CT
- Diagnostic Test
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Breast Cancer, Head and Neck Cancer, Oligoprogressive, Other Cancer, Sarcoma
- Interventions
- Ablative local therapy
- Device
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2033
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Gynecologic Cancer, Gynecologic Tumor, Head and Neck Cancer, Head and Neck Tumor, Melanoma, Ovarian Cancer, Thoracic Cancer, Thoracic Tumor
- Interventions
- Enhanced usual care, IM@Home
- Behavioral
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 324 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Head and Neck Cancer
- Interventions
- NYU Electronic Patient Visit Assessment (ePVA), Usual Care
- Behavioral
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 270 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 5
- States / cities
- Kansas City, Kansas • New York, New York • Philadelphia, Pennsylvania + 1 more
- Conditions
- Head and Neck Cancer, Head and Neck Cancers, Lip Cancer, Lip Neoplasms, Lung Cancer
- Interventions
- Phlebotomy, Tumor biopsy
- Procedure
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2027
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Breast Cancer, Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis of Indeterminate Potential (CHIP), Colorectal (Colon or Rectal) Cancer, Endometrial Adenocarcinoma, Esophageal Adenocarcinoma, Gastric (Stomach) Cancer, Head and Neck Cancer, Lung Cancer (Diagnosis), Osteochondroma, Ovarian Adenocarcinoma, Sarcoma, Solid Cancers, Spitz Nevus, Therapy-Related Acute Myeloid Leukemia, Therapy-Related MDS, Uterine Adenocarcinoma
- Interventions
- Samples
- Other
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2035
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Advanced Solid Tumors Cancer, Bladder Cancer, Cancer, Colorectal Cancer, DMMR Colorectal Cancer, Endometrial Cancer, Head and Neck Cancer, Immunotherapy, Kidney Cancer, Liver Cancer, MSI-H Colorectal Cancer, Melanoma (Skin Cancer), NSCLC (Non-small-cell Lung Cancer), Skin Cancer, TNBC, Triple Negative Breast Cancer
- Interventions
- Biopsy
- Procedure
- Lead sponsor
- Elephas
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2038
- U.S. locations
- 8
- States / cities
- Fort Smith, Arkansas • Frederick, Maryland • Springfield, Missouri + 4 more
- Conditions
- Brain Tumor, Head and Neck Cancer
- Interventions
- MRI, Neurocognitive Testing, substructure informed planning
- Diagnostic Test · Other · Radiation
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Other
- Eligibility
- 1 Year to 26 Years
- Enrollment
- 338 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2035
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia • Baltimore, Maryland
About this Head and Neck Cancer clinical trials directory page
- What this page lists
- U.S. ClinicalTrials.gov public records that list Head and Neck Cancer as a study condition, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
- How to narrow results
- Use the filters above to scope by intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Head and Neck Cancer.
- Where the data comes from
- Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, ranking of trials by quality, or AI-generated medical summaries.
Related: all condition pages, browse by drug or therapy, browse by U.S. city, browse by sponsor, or open the full search for Head and Neck Cancer.